Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China · Delayed Price · Currency is CNY 11.26
+0.67 (6.33%)
Jul 16, 2025, 2:45 PM CST
SHE:300942 Revenue
Shenzhen Bioeasy Biotechnology had revenue of 49.34M CNY in the quarter ending March 31, 2025, with 35.28% growth. This brings the company's revenue in the last twelve months to 237.12M, up 3.15% year-over-year. In the year 2024, Shenzhen Bioeasy Biotechnology had annual revenue of 224.25M, down -11.75%.
Revenue (ttm)
237.12M
Revenue Growth
+3.15%
P/S Ratio
19.11
Revenue / Employee
493.99K
Employees
480
Market Cap
4.53B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |